Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: HIV Med. 2019 Mar 29;20(5):317–329. doi: 10.1111/hiv.12726

Table 3b:

HIV-stratified mortality risk by diagnosis of major depressive disorder (defined by ICD-9 code) in the Veterans Aging Cohort Study (VACS)

Hazard ratio [95% CI]
HIV uninfected HIV infected
Model 3 No major depressive disorder 1 (ref) 1 (ref)
Major depressive disorder 1.06 (1.02, 1.11) 1.04 (0.99, 1.09)
Model 4 No major depressive disorder 1 (ref) 1 (ref)
Major depressive disorder 0.98 (0.94, 1.02) 0.99 (0.95, 1.04)
Model 5 No major depressive disorder 1 (ref) 1 (ref)
Major depressive disorder 1.02 (0.98, 1.07) 1.01 (0.96, 1.06)
Model 6 No major depressive disorder 1 (ref) 1 (ref)
Major depressive disorder 1.01 (0.96, 1.05) 0.97 (0.92, 1.02)

Model 3 adjusted age, sex, race, prevalent cardiovascular disease, chronic obstructive pulmonary disease, cancer, diabetes, systolic blood pressure, diastolic blood pressure, total cholesterol, estimated glomerular filtration rate, hemoglobin, and hepatitis C seropositivity. Model 4 adjusted for 3 for body mass index, smoking status, alcohol use, cocaine use. Model 5 adjusted Model 3 for baseline diagnosis of schizophrenia, bipolar disorder, and post-traumatic stress disorder. Model 6 adjusted Model 3 for baseline prescription of selective serotonin reuptake inhibitors and tricyclic antidepressant medications. All Models for the HIV-infected participants were then further adjusted for baseline use of antiretroviral therapy, CD4 cell count, and HIV-1 RNA level